Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-05-28

FDA Approved: SKLICE — Supplemental Application (Azurity Pharmaceuticals)

View source ↗

Summary

The FDA approved a supplemental application for SKLICE (ivermectin), manufactured by Azurity Pharmaceuticals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SKLICE (ivermectin)

Snippet

SUPPL AP for SKLICE (IVERMECTIN)